Cargando…

Linoleic Acid‐Derived Oxylipins Differentiate Early Stage Alcoholic Hepatitis From Mild Alcohol‐Associated Liver Injury

Alcohol‐associated liver disease (ALD) is a spectrum of liver disorders ranging from steatosis to steatohepatitis, fibrosis, and cirrhosis. Alcohol‐associated hepatitis (AH) is an acute and often severe form of ALD with substantial morbidity and mortality. The mechanisms and mediators of ALD progres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warner, Dennis, Vatsalya, Vatsalya, Zirnheld, Kara H., Warner, Jeffrey B., Hardesty, Josiah E., Umhau, John C., McClain, Craig J., Maddipati, Krishnarao, Kirpich, Irina A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183177/ https://www.ncbi.nlm.nih.gov/pubmed/34141982 http://dx.doi.org/10.1002/hep4.1686

Ejemplares similares

Soluble Epoxide Hydrolase Inhibition in Liver Diseases: A Review of Current Research and Knowledge Gaps
por: Warner, Jeffrey, et al.
Publicado: (2020)

Elevated Linoleic Acid (A Pro-Inflammatory PUFA) and Liver Injury in a Treatment Naive HIV-HCV Co-Infected Alcohol Dependent Patient
por: Vatsalya, Vatsalya, et al.
Publicado: (2016)

Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease
por: Warner, Jeffrey Barr, et al.
Publicado: (2022)

Fpr2(−/−) Mice Developed Exacerbated Alcohol-Associated Liver Disease
por: Hardesty, Josiah E., et al.
Publicado: (2023)

Human Beta Defensin 2 Ameliorated Alcohol-Associated Liver Disease in Mice
por: Warner, Jeffrey B., et al.
Publicado: (2022)

Rodent Models of Alcoholic Liver Disease: Role of Binge Ethanol Administration
por: Ghosh Dastidar, Shubha, et al.
Publicado: (2018)

Porphyromonas gingivalis as a Possible Risk Factor in the Development/Severity of Acute Alcoholic Hepatitis
por: Zhou, Yun, et al.
Publicado: (2018)

Ethanol and unsaturated dietary fat induce unique patterns of hepatic ω-6 and ω-3 PUFA oxylipins in a mouse model of alcoholic liver disease
por: Warner, Dennis R., et al.
Publicado: (2018)

Ileum Gene Expression in Response to Acute Systemic Inflammation in Mice Chronically Fed Ethanol: Beneficial Effects of Elevated Tissue n-3 PUFAs
por: Hardesty, Josiah E., et al.
Publicado: (2021)

Interaction of Heavy Drinking Patterns and Depression Severity Predicts Efficacy of Quetiapine Fumarate XR in Lowering Alcohol Intake in Alcohol Use Disorder Patients
por: Vatsalya, Vatsalya, et al.
Publicado: (2020)

Metabolic Profiling of Bile Acids in the Urine of Patients with Alcohol‐Associated Liver Disease
por: He, Liqing, et al.
Publicado: (2021)

Metabolic Analysis of Nucleosides/Bases in the Urine and Serum of Patients with Alcohol-Associated Liver Disease
por: He, Liqing, et al.
Publicado: (2022)

Fat-1 Transgenic Mice With Augmented n3-Polyunsaturated Fatty Acids Are Protected From Liver Injury Caused by Acute-On-Chronic Ethanol Administration
por: Warner, Jeffrey, et al.
Publicado: (2021)

Prevalence and Treatment for Alcohol Use Disorders Based on Kentucky Medicaid 2012–2019 Datasets
por: Hu, Huirong, et al.
Publicado: (2022)

Su319 KEY PRO-INFLAMMATORY/INJURY FEATURES OF COVID-19 PATIENTS WITH ALCOHOL USE
por: Rios, Cristian D., et al.
Publicado: (2021)

Heavy Alcohol Drinking Associated Akathisia and Management with Quetiapine XR in Alcohol Dependent Patients
por: Kurlawala, Zimple, et al.
Publicado: (2016)

Novel Biomarker for the Diagnosis and Prognosis of Acute Alcoholic Hepatitis
por: Vatsalya, Vatsalya
Publicado: (2020)

Novel paradigms for the gut–brain axis during alcohol withdrawal, withdrawal-associated depression, and craving in patients with alcohol use disorder
por: Vatsalya, Vatsalya, et al.
Publicado: (2023)

Exacerbation of Hangover Symptomology Significantly Corresponds with Heavy and Chronic Alcohol Drinking: A Pilot Study
por: Vatsalya, Vatsalya, et al.
Publicado: (2019)

Transcriptional signatures of the small intestinal mucosa in response to ethanol in transgenic mice rich in endogenous n3 fatty acids
por: Hardesty, Josiah E., et al.
Publicado: (2020)

Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope
por: Gala, Khushboo S., et al.
Publicado: (2020)

Characterization of Early-Stage Alcoholic Liver Disease with Hyperhomocysteinemia and Gut Dysfunction and Associated Immune Response in Alcohol Use Disorder Patients
por: Vatsalya, Vatsalya, et al.
Publicado: (2020)

Role of Nutrition in Alcoholic Liver Disease: Summary of the Symposium at the ESBRA 2017 Congress
por: Kharbanda, Kusum K., et al.
Publicado: (2018)

Development, Prevention, and Treatment of Alcohol-Induced Organ Injury: The Role of Nutrition
por: Barve, Shirish, et al.
Publicado: (2017)

Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences
por: Joshi-Barve, Swati, et al.
Publicado: (2015)

2263: The effect of family history, alcohol expectancies, and sex differences on hangover symptoms following intravenous alcohol self-administration in nondependent drinkers
por: Daniel Ester, Corbin, et al.
Publicado: (2018)

Alcoholic Liver Disease: Update on the Role of Dietary Fat
por: Kirpich, Irina A., et al.
Publicado: (2016)

Dysregulation in Plasma ω3 Fatty Acids Concentration and Serum Zinc in Heavy Alcohol-Drinking HCV Patients
por: Vatsalya, Vatsalya, et al.
Publicado: (2020)

Characterization of Hypomagnesemia in Alcoholic Hepatitis Patients and Its Association with Liver Injury and Severity Markers
por: Winrich, Evan J., et al.
Publicado: (2023)

Exposure-Response Relationships during Free-Access Intravenous Alcohol Self-Administration in Nondependent Drinkers: Influence of Alcohol Expectancies and Impulsivity
por: Stangl, Bethany L., et al.
Publicado: (2016)

Repurposing Treatment of Wernicke–Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile
por: Vatsalya, Vatsalya, et al.
Publicado: (2021)

Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers
por: Vatsalya, Vatsalya, et al.
Publicado: (2015)

Microbiome dysbiosis and alcoholic liver disease(☆)
por: Li, Fengyuan, et al.
Publicado: (2019)

Evaluation of health determinants for sustaining workability in aging US workforce
por: Vatsalya, Vatsalya, et al.
Publicado: (2013)

Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis
por: Sagaram, Manasa, et al.
Publicado: (2022)

Cytokines and Alcoholic Liver Disease
por: McClain, Craig J., et al.
Publicado: (1997)

Illustration of Gut–Thyroid Axis in Alcohol Use Disorder: Interplay of Gut Dysfunction, Pro-Inflammatory Responses, and Thyroid Function
por: Sagaram, Manasa, et al.
Publicado: (2022)

cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease
por: Elnagdy, Mohamed, et al.
Publicado: (2020)

Metagenomic Analyses of Alcohol Induced Pathogenic Alterations in the Intestinal Microbiome and the Effect of Lactobacillus rhamnosus GG Treatment
por: Bull-Otterson, Lara, et al.
Publicado: (2013)

Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms
por: Li, Fengyuan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ofo43mra5c0ac3jtbbk8rbak10